day 1 agenda

4th Global Experts Meeting on FRONTIERS IN NEUROSCIENCES July 08 - 09, 2024 at Paris, France 
Scientific Program
Day-1 - July 08, 2024
08:20-08:45 Registrations
08:45- 09:00 Opening Remarks
Keynote Session
09:00-09:30 Nanotechnology for Pain Management: A Mini Review
Jacques E Chelly, University of Pittsburgh, USA 
09:30-10:00 The Current Status of Botulinum Toxin Therapy in Motor Disorders
BAHMAN JABBARI, Yale University, USA
10:00-10:30 Keynote slot Available
Group photo @ Garden
10:40- 11:00      Refreshment Break 
Technical Session-I : TBA
11:00- 11:20 Hypothalamic pituitary adrenal axis hyperactivity is normalized after successful intermittent theta burst stimulation in resistant depressed patients
Fabrice Duval, Centre Hospitalier Rouffach, France
11:20- 11:40 Neurofeedback as a tool to mitigate symptoms in mental illness and a tool of clinical neuroscience
Margaret Niznikiewicz, Harvard Medical School, USA
11:40- 12:00 Selective deletion of glutamatergic CYLD leads to aberrant excitatory synaptic activities in basolateral amygdala associating with enhanced cued fear in mice
Cheng Long, South China Normal University, china
12:00- 12:20 Morphology based Self supervised Deep Learning for Quantitative Susceptibility Mapping
Rongpin Wang, Guizhou Provicial People's Hospital, china
12:20- 12:40 Structures of drug specific monoclonal antibodies (mAbs) bound to opioids reveal a common mode of binding and allow for engineering of mAbs against fentanyl and carfentanil with improved binding
Marie Pancera, Fred Hutchinson Cancer Center, USA
12:40- 13:00 Neuroprotective effect of 1,25 dihydroxyvitamin D3 against hyperoxia induced brain injury in premature rats
Rong Chen, Guizhou Provincial People's Hospital, China
13:00- 13:20 Neuroprotective effect of 1,25 dihydroxyvitamin D3 against hyperoxia induced brain injury in premature rats
Dongfan Xiao, Guizhou hospital of shanghai children's medical center, China 
13:20-14:00 Lunch @ Restaurant
14:00- 14:20 Why can modulation of a6 containing GABAA receptors reduce the symptoms of multiple neuropsychiatric disorders?
Werner Sieghart, Medical University Vienna, Austria  
14:20- 14:40 Stellate ganglion block for the treatment of the dysautonomia of “Long Covid”
David Gaskin, Republic Pain Specialists, Maverick Medical Education, USA
14:40- 15:00 The interplay of dopamine metabolism abnormalities and mitochondrial defects in the pathogenesis of schizophrenia
Haiyun Xu, Wenzhou Medical University, China
15:00- 15:20 TBA
Daniel J Liebl, University of Miami, USA
15:20- 15:40 The RNA editing patterns are different in blood of euthymic and depressed bipolar patients
Dinah Weissmann, Alcediag, France 
15:40- 16:00 Leveraging Tumor Suppressor MicroRNA-122 and Oncogenic Kinases Inhibitor Abemaciclib to Treat Acute Brain Injuries
Da Zhi Liu, University of California, USA
16:00- 16:20 Behavioral And Molecular investigation Of the Effect Of Dexmedetomidine (DEX) On Learning And Memory in Experimental Schizophrenia-Like Model Mice
Esma Deniz Barc, Yuksek Ihtisas University, Turkey
16:20- 16:40 TAB
Lin Liu, University of Florida, USA
16:40- 17:00 Analysis of Pyramidal Cells in Layer III of Brodmann Area 46 in Schizophrenia and Depression
Jens Randel Nyengaard, Aarhus University, Denmark
Panel Discussions
Day-1 Concludes
Note: This is a tentative program and subject to change
We are still accepting the abstracts. To book your slot, contact Dr. Anakaren Felix at  anakaren_f@neurosciences-research.org

day 2 agenda

Day-2 - July 09, 2024
 
10:00-11:00 About the Continuity of our Consciousness A concept based on scientific studies on Near-Death Experience Pim van Lommel cardiologist  
Pim van Lommel, University of Utrecht, Netherlands
11:00-11:20 Longitudinal Temperament Pathways to ADHD Between Childhood and Adolescence
Michelle Martel, University of Kentucky, USA
11:20-11:40 Developing HDAC4-selective protein degraders to investigate the role of HDAC4 in Huntingtons disease pathology
Will Esmieu, Charles River Laboratories, UK
Technical Session-II TBA
Chairs: TBA
11:40- 12:00 The Therapeutic Potentials of Dimethyltryptamine against Ischemia/Reperfusion Injury of the Brain
Ede Frecska, University of Debrecen, Hungary
12:00- 12:20 A study of assisted screening for Alzheimers disease based on handwriting and gait analysis
Hengnian QI, Huzhou University, China
12:20- 12:40 Analysis of Pyramidal Cells in Layer III of Brodmann Area 46 in Schizophrenia and Depression
Jens Randel Nyengaard, Aarhus University, Denmark
12:40- 13:00 Distribution and synaptic organization of substance P like immunoreactive neurons in the mouse retina
Jun Zhang, Wenzhou Medical University, China 
13:00- 13:20 Slot Available
13:20-14:00 Lunch @ Restaurant
14:00- 14:20 Effects of a probiotic suspension SymproveTM on a rat early-stage Parkinsons disease model
Audrey Mercer, UCL, UK 
14:20- 14:40 DEFECTIVE LIPID METABOLISM CONTRIBUTES TO SYNAPTIC DYSFUNCTION IN A RAT MODEL OF HUMAN SPINOCEREBELLAR ATAXIA-34 CAUSED BY W246G-MUTANT ELOVL4
Martin-Paul Agbaga, The University Of Oklahoma Health Sciences Center, USA
14:40- 15:00 Genetic architecture of tinnitus 
Royce Ellen Clifford, University of California San Diego, USA
15:00- 15:20 Navigated simultaneous lateral minimally invasive tubular and posterior mini-open access for removal and revision of triangular sacroiliac joint implants: Technical note
Shahaan S. Razak, Beth Israel Deaconess Medical Center, USA 
15:20- 15:40 Slot Available
15:40- 16:00 Experience-dependent neuroplasticity in the auditory system
Aysegul Gungor Aydin, Rutgers University, USA
Closing Remarks
Note: This is a tentative program and subject to change
We are still accepting the abstracts. To book your slot, contact Dr. Anakaren Felix at  anakaren_f@neurosciences-research.org

posters agenda

Will Update soon.

posters agenda

Day-2 - July 9, 2024 (Parallel Virtual session)                    
 
10:00- 10:20 Bioinformatics and network pharmacology analysis of drug targets and mechanisms related to the comorbidity of epilepsy and migraine
Guohui Jiang, North Sichuan Medical College, China
10:20- 10:40 New, non canonical role of complement as synaptic modulator in neurological diseases
Anna Maria Pittaluga,University of Genoa, Italy
10:40- 11:00 Expression of a secretable, cell penetrating CDKL5 protein enhances gene therapy efficacy in a mouse model of CDKL5 Deficiency Disorder and patient derived cortical organoids
Giorgio Medici, University of Bologna, Italy
11:00- 11:20 The Gut Brain Axis in Depression associated with HIV 1 and Opioid Use
Shamsudheen Moidunny, University of Miami Miller School of Medicine, USA
11:20-11:40                      SPEAKER SLOT AVAILABLE
11:40- 12:00 A Novel Robot based Paradigm for Intelligent Assessment of Parkinson's Disease   
Yokhesh Krishnasamy Tamilselvam, University of Western Ontario, Canada
12:00- 12:20 Attention is tuned to relative features in visual search without prior knowledge of the context
Stefanie I. Becker, The University of Queensland, Australia
12:20- 12:40 An exploratory multi-institutional prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma
Toshihide Tanaka, The Jikei University School of Medicine, Japan
12:40- 13:00 The experience of Autistic Children and their Parents when visiting a Diagnostic Imaging Department
Jane Harvey Lloyd, University of Leeds, UK
13:00- 13:20 Mechanism of Qihuang needle therapy in the management of tic disorders: a clinical trial protocol
Bingxu Jin, Panyu Hospital of Traditional Chinese Medicine, China 
13:20- 13:40 Evidence of language acquisition in children with profound cognitive delay
Rosemary Woods, De Montfort University, UK
13:40- 14:00 Enhanced Retinal Glycolytic Activity Through the Rod Signal Pathway in Response to Altered Visual Stimuli
Zhikuan Yang, Central South University, China 
14:00-14:20                      SPEAKER SLOT AVAILABLE
14:20- 14:40 Bridging the Gap: Brainstem Insights into Autism Spectrum Disorders
Ronny Geva, Bar Ilan University, israel
14:40- 15:00 Sequences and their shuffling may crucially impact coordinated reset stimulation
Justus Alfred Kromer, Stanford University, USA
15:00- 15:20 Single-nucleus RNA-sequencing uncovers the cell type-dependent transcriptomic changes in the cingulate cortex after peripheral nerve injury
Xiang-Yao Li, Zhejiang University, China 
15:20- 15:40 Mitochondrial Transfer as a Novel Therapeutic Approach for Alzheimer's Disease
Haya Lorberboum-Galski, The Hebrew University of Jerusalem, Israel
15:40-16:00                      SPEAKER SLOT AVAILABLE
16:00- 16:20 Cortical astroglia pathology in depression: insight from animal models demonstrate a link to anhedonia
Mounira Banasr, Centre of Addiction and Mental Health, Canada 
16:20- 16:40 Identification of novel and de novo variant in the SCN1A gene confirms Dravet syndrome in Moroccan child: a case report
Hinde El Mouhi, Sidi Mohamed Ben Abdellah University, Morocco
16:40- 17:00                      SPEAKER SLOT AVAILABLE
17:00- 17:20 Cisternal nicardipine for prevention of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage
Giulia Cossu, University Hospital of Lausanne, Switzerland
17:20-17:40  SPEAKER SLOT AVAILABLE
Note: This is a tentative program and subject to change
We are still accepting the abstracts. To book your slot, contact Dr. Anakaren Felix at  anakaren_f@neurosciences-research.org

Download